We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+11.44%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$96.2B
AUM Growth
+$13.8B
(+17%)
Cap. Flow
+$2.5B
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
19.24%
Holding
5,235
New
767
Increased
1,692
Reduced
1,826
Closed
817
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$410M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$308M |
| 3 |
Eli Lilly
LLY
|
+$292M |
| 4 |
Costco
COST
|
+$291M |
| 5 |
Ford
F
|
+$257M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$368M |
| 3 |
Fair Isaac
FICO
|
+$197M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$194M |
| 5 |
Carrier Global
CARR
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.55% |
| 2 | Consumer Discretionary | 7.1% |
| 3 | Financials | 4.87% |
| 4 | Healthcare | 4.79% |
| 5 | Industrials | 4.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
4D Molecular Therapeutics
FDMT
$526M
| $196K | ﹤0.01% |
+52,879
| New | +$186K |
|
3977
Sonos
SONO
$1.75B
| $195K | ﹤0.01% |
18,079
-500
| -3% | -$4.86K |
|
3978
PUT
Eos Energy Enterprises
EOSE
$1.23B
| $194K | ﹤0.01% |
37,900
+15,900
| +72% | +$77.9K |
|
3979
Riverview Bancorp
RVSB
$107M
| $193K | ﹤0.01% |
+35,039
| New | +$203K |
|
|
FLNA
3980
Filana Therapeutics
FLNA
$43M
| $193K | ﹤0.01% |
106,469
+41,345
| +63% | +$73.6K |
|
3981
BRC Group Holdings
RILY
$277M
| $192K | ﹤0.01% |
+64,789
| New | +$199K |
|
3982
Oportun Financial
OPRT
$257M
| $192K | ﹤0.01% |
26,829
-49,595
| -65% | -$297K |
|
3983
PUT
Cerence
CRNC
$382M
| $192K | ﹤0.01% |
18,800
-21,100
| -53% | -$186K |
|
|
INZY
3984
DELISTED
Inozyme Pharma
INZY
| $192K | ﹤0.01% |
+47,927
| New | +$119K |
|
3985
Invesco DB US Dollar Index Bearish Fund
UDN
$107M
| $191K | ﹤0.01% |
10,113
| – | – |
|
3986
Douglas Elliman
DOUG
$155M
| $188K | ﹤0.01% |
81,222
-34,937
| -30% | -$74.6K |
|
3987
InfuSystem Holdings
INFU
$184M
| $188K | ﹤0.01% |
+30,156
| New | +$167K |
|
3988
NerdWallet
NRDS
$584M
| $188K | ﹤0.01% |
17,144
| – | – |
|
|
IRBT
3989
CALL
DELISTED
iRobot
IRBT
| $188K | ﹤0.01% |
60,000
-100
| -0.2% | -$277 |
|
3990
Candel Therapeutics
CADL
$700M
| $187K | ﹤0.01% |
36,951
-38,127
| -51% | -$196K |
|
3991
Ecopetrol
EC
$32.9B
| $187K | ﹤0.01% |
21,108
+4,443
| +27% | +$39.3K |
|
3992
KRONOS Worldwide
KRO
$761M
| $186K | ﹤0.01% |
30,073
-66,297
| -69% | -$455K |
|
3993
Olema Pharmaceuticals
OLMA
$1.02B
| $186K | ﹤0.01% |
43,606
+20,673
| +90% | +$92.2K |
|
|
HAPN
3994
PUT
Happen Inc
HAPN
$2.08B
| $185K | ﹤0.01% |
15,400
-2,100
| -12% | -$21.8K |
|
3995
iShares Global Clean Energy ETF
ICLN
$2.38B
| $184K | ﹤0.01% |
14,053
+100
| +0.7% | +$1.23K |
|
3996
Children's Place
PLCE
$53.6M
| $184K | ﹤0.01% |
41,504
-9,914
| -19% | -$55.8K |
|
3997
Pliant Therapeutics
PLRX
$67.5M
| $183K | ﹤0.01% |
157,844
+4,149
| +3% | +$5.86K |
|
3998
CALL
Viasat
VSAT
$9.79B
| $183K | ﹤0.01% |
12,500
| – | – |
|
|
EEX
3999
DELISTED
Emerald Holding
EEX
| $182K | ﹤0.01% |
37,577
+15,934
| +74% | +$69.4K |
|
4000
D-Wave Quantum
QBTS
$6B
| $182K | ﹤0.01% |
+12,435
| New | +$146K |
|
Similar funds
Squarepoint's Q2 2025 Portfolio in Review
As of Q2 2025, Squarepoint held 5,235 positions worth $96.2B, up 17% from $82.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Squarepoint's Q2 2025 filing shows 767 new, 1,692 increased, 1,826 reduced and 817 closed positions. Its largest new stake was iShares MSCI EAFE ETF: 993,060 shares worth $88.8M. The largest sale was Microsoft, an estimated $1.48B.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
- Squarepoint's largest Q2 2025 buy was iShares MSCI EAFE ETF: 993,060 shares worth $88.8M.
- Squarepoint added most to Amazon in Q2 2025, an estimated $410M increase.
- Squarepoint's biggest Q2 2025 reduction was Microsoft, cutting an estimated $1.48B.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q2 2025, selling an estimated $194M.
- Squarepoint's ten largest holdings make up 19% of its $96.2B portfolio in Q2 2025.
- Squarepoint opened 767 new positions and closed 817 in Q2 2025.
- Squarepoint's portfolio value rose 17% quarter-over-quarter to $96.2B.
Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.